Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 21 for “"pharmaceutical economics"”.
-
Essays in pharmaceutical economics
This thesis consists of three empirical essays in pharmaceutical economics, which explore the role regulation plays in influencing firm behavior. In the first chapter I examine competition in the neglected disease submarket of the biopharmaceutical industry. Using a combination of novel panel data …
-
Pharmaceutical Industry Events and the Stock Market
… to three significant events relevant to the pharmaceutical drug pricing issue in the United States. We examine a few policies and solutions in e↵orts to assist with this issue. Using an event study methodology, we investigate the impact of the Generic Drug User Fee Act of 2012 (GDUFA) and …
-
An Economic and Regulatory Analysis of Gene Therapy Products Authorized by the US Food and Drug Administration and the European Medicines Agency
<p>Background: Gene therapy has recently emerged as an alternative for preventing and treating disease. Concerns have been expressed about the clinical value and the high cost of gene therapies.</p> <p>Objective: This study assessed the authorization process of gene therapy products by the Food and …
-
Resumes Of Diploma Theses (2014) for Master’s Degree in Pharmaceutical Management
… Resumes of diploma theses for Master's degree in Pharmaceutical Management. These theses were written and defended in 2014 at the The Faculty of Public Health, Medical University of Varna. List of Titles: COMPARATIVE ANALYSIS BETWEEN SCANDINAVIAN AND JAPANESE MODELS OF HUMAN RESOURCES MANAGEMENT …
-
An Analysis of Trends of Generic Drugs and Biologic Prices in the U.S.
<p><strong>Introduction:</strong> Drug prices are a significant problem for the US healthcare system. Generic and biosimilar market competition reduces drug and biologic prices, results in substantial savings, and improves patient access and outcomes. As the costs of healthcare and prescription …
-
Orphan Drugs: Designations, Approvals, and Prices in the US
<p><strong>Introduction.</strong> Rare disease drug approvals have accelerated significantly in recent years. Even with these advances, patients continue to face challenges in receiving treatment, with most rare diseases lacking any approved treatments. Moreover, even when a treatment is available, …
-
An Economic and Regulatory Analysis of Breast Cancer Drugs Approved by the US Food and Drug Administration
<p><strong>Introduction</strong></p> <p>Breast cancer is the most common cancer among women and the leading cause of cancer death among women worldwide. The pharmacological options for breast cancer include chemotherapy, hormone therapy, targeted therapy, and immunotherapy, which are used for the …
-
Renal Toxicity Warnings and Precautions of Drugs Marketed in the US
<p>INTRODUCTION: The use of drugs can lead to renal adverse effects prompting the need to include warnings and precautions on medication labels. Studies evaluating renal warnings and precautions need to be improved. This study assessed the characteristics of FDA renal toxicity warnings and …
-
Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies in Cystic Fibrosis: A Retrospective Evaluation of a Nationwide Specialty Pharmacy Database
<p>Background: Cystic fibrosis (CF) is a progressive, genetic disorder caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Patients with CF experience excessive mucus build up and infections leading to complications in the pancreas, lungs, and other organs. …
-
Approvals, Utilization, and Cost of Biologics for the Treatment of Rheumatoid Arthritis
<p><strong>Introduction:</strong> RA treatment has been revolutionized by the development and approval of biologic disease-modifying antirheumatic drugs (bDMARDs). However, the approval status, utilization, and high cost of bDMARDs pose challenges in RA management.</p> …
-
Approvals and Prices of Systemic Antibiotics in Saudi Arabia and the United States
<p><strong>Introduction</strong></p> <p>Antibiotics is one of the therapeutic classes with the highest level of consumption in the world. Despite the global diffusion of antibiotics, their availability and prices vary by country. This study assessed differences in the availability and prices of …
-
Preferences and Willingness to Pay for Osteoarthritis Treatments among the Medicare Population
<p>The design of this study is a non-random cross sectional survey to determine Medicare beneficiaries’ preferences and willingness to pay for osteoarthritis (OA) treatments. The population of interest in this study is the Medicare eligible (over age 65) population in Memphis, TN, and surrounding …
-
The Value of Online Medication Rating Systems to Older Adults and Their Association with Self-Reported Outcomes
<p>The Internet is a powerful and very popular vehicle for distributing judgment-free health information to patients. Multiple studies have examined the role of online health information as well as physician-rating websites in health care. Studies have examined the value of online drug information …
-
Authorizations, Prices, and Labeling Differences of Therapeutic Biologics Marketed in the United States and Saudi Arabia
<p>BACKGROUND: Since 1982, Saudi Arabia (SA) and the United States (US) have seen an increase in therapeutic biologics authorization. However, each country has regulatory regulations governing the approval of these cutting-edge drugs. The high cost of biologics financially burdens healthcare …
-
An Exploration of Ambulatory Visits and Medications Prescribed for Patients Diagnosed with Lupus Erythematosus in the United States
<p>This dissertation sought to understand the management and treatment of patients diagnosed with lupus erythematosus. To accomplish the objectives of this research, three studies were conducted. First, a systematic literature review was done to assess the current landscape of available clinical …
-
Cost-Effectiveness Analysis of Tisagenlecleucel, Blinatumomab, and Clofarabine for Treatment of B-cell Precursor Acute Lymphoblastic Leukemia
<p>Acute lymphoblastic leukemia (ALL) is a common type of adolescent and young adult leukemia in the United States (U.S.). Patients who are refractory or relapsed after receiving two or more lines of systemic therapy have the option of taking tisagenlecleucel. Due to the high cost of this …
-
Use of Medications and Pharmacists’ Role in Improving the Quality of Life in Children with Bronchial Asthma // Лекарствена употреба и роля на фармацевтите за подобряване качеството на живот при деца с бронхиална астма
… that may be helpful for the professionals in pharmaceutical science and practice. Its substantial contribution is the feasible implementation of the developed approach focused on the pharmacist activities in providing comprehensive care for paediatric patients with asthma. The pharmacist …
-
The Pharmacist's Role in Consulting Patients with Joint Diseases // Роля на магистър-фармацевта при консултиране на болни със ставни заболявания
… through the application of individualized pharmaceutical care. Analyzing the available modern literature on the provision of pharmaceutical care, the features of pharmaceutical care in patients with chronic degenerative and inflammatory joint diseases are highlighted. An algorithm for …
-
Analysis of Out-of-Pocket Expenditures of Oral Oncologics for Tennessee Recipients of Medicare Part D
<p><strong>Background</strong>: There are few studies that examine patients' costs of oral oncology drugs from Medicare Part D plan providers. These drugs can impose a financial burden to beneficiaries, and, due to their cost, place beneficiaries in the coverage gap in a short period of time. In …
Page 1 of 2